the glocalized network in theragenomic and personalized medicine and the genetics of individual patients safety of drugs
Last Updated on December 30, 2018 by Joseph Gut – thasso December 30, 2018 – Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is an aggressive and rare disease of the bone marrow and blood that can affect multiple organs, including the …
Last Updated on December 20, 2018 by Joseph Gut – thasso December 20, 2018 – This is very troubling news for all patients worldwide with diabetes and who are under therapy with drugs out of the DPP-4 class of inhibitors: A …
Cholangiocarcinoma: Diabetes Drugs In DPP-4 Inhibitor Class Associated With Doubled Risk Read more »
Last Updated on December 19, 2018 by Joseph Gut – thasso December 12, 2018 – The application of CRISPR/Cas9 based molecular technology in the field of gene editing (or genome editing) has recently had its exploded limelight exposure for a couple …
CRISPR/Cas9 for the Treatment of Duchenne Muscular Dystrophy: Prime time already? Read more »
Last Updated on December 4, 2018 by Joseph Gut – thasso December 04, 2018 – The American Food and Drug Administration (FDA) has just approved its first ever treatment, Amifampridine (Firdapse), for Lambert-Eaton myasthenic syndrome (LEMS), a rare autoimmune disorder …
First ever treatment for Lambert-Eaton myasthenic syndrome (LEMS) FDA approved Read more »